What Causes Neovascularization In The Eye? Root Causes

Neovascularization in the eye is the growth of new, abnormal blood vessels on the retina or other parts of the eye. These vessels are fragile and leak fluid or blood, which can damage vision. The root cause is almost always oxygen deprivation to the retina, which triggers the release of growth factors that stimulate new vessel growth.

What Is Ocular Neovascularization?

Neovascularization is the medical term for the formation of new blood vessels. In the eye, this usually happens in the retina, the light-sensitive tissue at the back of the eye. It can also occur in the cornea, the iris, or the choroid layer beneath the retina.

These new vessels are not like the healthy blood vessels you were born with. They are structurally weak and abnormally permeable. They leak plasma and lipids into the surrounding tissue, and they can rupture and bleed. This fluid and blood damages the delicate retinal cells, leading to vision loss.

The process is driven by a protein called vascular endothelial growth factor (VEGF). When the retina does not get enough oxygen, it produces more VEGF. This protein signals the body to grow new blood vessels. In a healthy eye, this process is tightly controlled. In a diseased eye, it runs unchecked.

What Causes Neovascularization In The Eye?

The underlying trigger is retinal ischemia, which means the retina is not receiving enough blood and oxygen. When retinal cells are starved of oxygen, they release VEGF to try to restore blood flow. The problem is that the new vessels that grow are abnormal and cause more harm than good.

There are several diseases that create this oxygen-deprived environment. These are the root causes of ocular neovascularization:

• Diabetic retinopathy — high blood sugar damages the small blood vessels in the retina, blocking blood flow.
• Retinal vein occlusion — a blockage in the veins that drain blood from the retina causes pressure and leakage.
• Age-related macular degeneration (wet form) — abnormal vessels grow beneath the retina in the macula.
• Retinopathy of prematurity — occurs in premature infants whose retinas are not fully developed.
• Sickle cell retinopathy — sickle-shaped red blood cells block retinal blood vessels.
• Ocular ischemic syndrome — severe blockage of the carotid artery reduces blood flow to the entire eye.

Each of these conditions has a different starting point, but they all converge on the same final pathway: retinal hypoxia and VEGF-driven vessel growth.

How Diabetic Retinopathy Leads To Neovascularization

Diabetes is the most common cause of ocular neovascularization in working-age adults. Chronically elevated blood sugar damages the endothelial cells that line retinal capillaries. These damaged vessels lose their ability to regulate what passes through their walls.

Over years, some capillaries become blocked entirely. The retina responds by producing VEGF. This marks the transition from non-proliferative diabetic retinopathy to proliferative diabetic retinopathy. Proliferative means the retina is now growing new vessels.

These new vessels grow along the surface of the retina and into the vitreous gel that fills the eye. They are fragile and prone to bleeding. When they bleed, the blood can cloud vision suddenly. Scar tissue can also form around these vessels and pull on the retina, causing a retinal detachment.

Good blood sugar control substantially reduces the risk of progression. So does controlling blood pressure and cholesterol. But once neovascularization begins, it requires active treatment.

Retinal Vein Occlusion And Its Effects

A retinal vein occlusion is essentially a blood clot in one of the veins that drains blood from the retina. This blockage raises pressure in the retinal circulation and causes fluid and blood to leak into the retina.

The retina becomes hypoxic because blood cannot drain properly. The tissue responds by releasing VEGF, which triggers neovascularization. This can happen on the retina itself, in the iris, or in the angle where the iris meets the cornea.

Neovascularization in the iris is particularly dangerous. It can block the eye’s natural drainage system and cause a severe form of glaucoma called neovascular glaucoma. This condition is difficult to treat and can lead to permanent vision loss.

Retinal vein occlusion is more common in people with high blood pressure, glaucoma, and diabetes. It typically affects one eye. Treatment focuses on managing the leak and preventing neovascularization.

Wet Age-Related Macular Degeneration

Age-related macular degeneration (AMD) affects the macula, the central part of the retina responsible for sharp, detailed vision. There are two forms: dry and wet. The wet form is the one associated with neovascularization.

In wet AMD, abnormal blood vessels grow beneath the retina from the choroid layer. These vessels leak fluid and blood, causing rapid damage to the macula. This is why wet AMD causes sudden changes in central vision, while dry AMD progresses more slowly.

The exact trigger for this vessel growth is not fully understood. Chronic inflammation and oxidative stress are believed to play a role. Genetic factors also matter. People with a family history of AMD have a higher risk.

Wet AMD is a leading cause of severe vision loss in people over 60. Anti-VEGF injections are the standard treatment and can often stabilize or improve vision if started early.

How Anti-VEGF Treatments Work

Anti-VEGF drugs are injected directly into the eye. They bind to VEGF and prevent it from signaling blood vessel growth. This stops the formation of new vessels and reduces leakage from existing ones.

These injections are the first-line treatment for most forms of ocular neovascularization. They are used for diabetic retinopathy, retinal vein occlusion, and wet AMD. The goal is to prevent further vision loss and, in some cases, to improve vision.

Treatment schedules vary. Some patients need injections monthly. Others can go several months between injections. The frequency depends on the disease, its severity, and how the eye responds.

Laser therapy is another option in certain cases. Panretinal photocoagulation uses a laser to destroy areas of the retina that are producing VEGF. This is less commonly used now that anti-VEGF injections are available, but it still has a role in some situations.

Can Neovascularization Be Prevented?

Prevention depends on the underlying cause. For diabetic retinopathy, strict blood sugar control is the most effective preventive measure. The Diabetes Control and Complications Trial established that intensive glucose control reduces the risk of retinopathy progression.

Managing blood pressure and cholesterol also reduces risk. Smoking cessation is important, as smoking impairs circulation. Regular eye exams are critical because neovascularization often develops before symptoms appear.

For wet AMD, prevention is less certain. A diet rich in leafy green vegetables, fish, and antioxidants is associated with lower risk. The AREDS2 formula of vitamins and minerals has been shown to slow progression in people with intermediate dry AMD, but it does not prevent wet AMD entirely.

For retinal vein occlusion, controlling blood pressure is the main preventive strategy. There is no way to predict or prevent the clot itself in most cases.

When To See An Eye Doctor

Many forms of ocular neovascularization cause no symptoms in their early stages. This is why routine eye exams are so important, especially for people with diabetes or a family history of eye disease.

Symptoms that warrant an urgent eye exam include:

• Sudden vision loss or a shadow in your field of vision
• Flashes of light or new floaters
• Blurred or distorted central vision
• Eye pain or redness

These symptoms can indicate bleeding, retinal detachment, or neovascular glaucoma. Prompt treatment can often prevent permanent vision loss.